Pamorelin LA 11.25
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Pamorelin LA 11.25 is a long-acting powder for injection containing triptorelin, a gonadotropin-releasing hormone analogue. Its labelling describes it mainly for the treatment of prostate cancer, and also for endometriosis and central precocious puberty in women. In prostate cancer it is described as reducing testosterone levels in men to prevent cancer cells from growing and to ease urination; in endometriosis it is described as preventing quick growth of endometrial tissue; and in precocious puberty it is described as delaying early puberty. It is injected under the skin by a medical professional, with the dose and frequency set by the doctor.
Product Information
The following description reflects information associated with triptorelin and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Prostate cancer — described as reducing testosterone levels in men to prevent cancer cells from growing and to make urination easier
- Endometriosis — described as preventing the quick growth of endometrial tissue and treating symptoms such as back pain, period pain, and pain during and after sex
- Central precocious puberty — described as delaying early puberty in a child showing adult features at around age 8 or 9
Described Dosage & Administration
- Injected under the skin by a medical professional, under the supervision of the doctor
- A medical supervisor recommends the medicine based on symptoms and certain lab tests; a proper schedule should be followed and no dose skipped
- Long-term use is described as possibly leading to weakened bones or low bone mineral density, so vitamin D and calcium supplements may be recommended alongside
Described Side Effects
Signs described as needing immediate attention include:
- Erectile dysfunction
- Hot flashes
- Back pain
- Weakened bones / low bone mineral density with long-term use
Any severe, persistent, or unexpected reaction requires prompt medical attention.
Precautions
- Always used under the supervision of the doctor
- Pre-existing conditions such as kidney or liver disease or osteoporosis should be disclosed; it is described as unsafe for pregnant women
- Alcohol should be avoided during treatment
- Menstrual cycles are described as stopping in women for 7–12 weeks; the doctor should be informed if periods still occur during treatment
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains triptorelin and is used mainly for prostate cancer, and also for endometriosis and central precocious puberty in women. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as a powder injected under the skin by a medical professional, with the dose, course, and frequency decided by the doctor.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.